Literature DB >> 24470340

Antibody-mediated rejection in liver transplantation: current controversies and future directions.

Timucin Taner1, Mark D Stegall, Julie K Heimbach.   

Abstract

Interest in the role of donor-specific human leukocyte antibodies in liver transplantation has been rekindled recently. Emerging evidence suggests that these antibodies may cause injury to the liver allograft. Here we review the clinical literature, highlight controversial results, and propose a path forward for the definition and better understanding of antibody-mediated injury to the liver.
© 2014 American Association for the Study of Liver Diseases.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24470340     DOI： 10.1002/lt.23826

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


  12 in total

1.  Current Issues in Liver Transplantation.

Authors:  James F Trotter
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-04

2.  Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants.

Authors:  Sandy Feng; John C Bucuvalas; Anthony J Demetris; Bryna E Burrell; Katherine M Spain; Sai Kanaparthi; John C Magee; David Ikle; Andrew Lesniak; Juan J Lozano; Estella M Alonso; Robert A Bray; Nancy E Bridges; Edward Doo; Howard M Gebel; Nitika A Gupta; Ryan W Himes; Annette M Jackson; Steven J Lobritto; George V Mazariegos; Vicky L Ng; Elizabeth B Rand; Averell H Sherker; Shikha Sundaram; Yumirle P Turmelle; Alberto Sanchez-Fueyo
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

Review 3.  Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.

Authors:  Antonio Cuadrado; David San Segundo; Marcos López-Hoyos; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 4.  Liver transplantation: Current status and challenges.

Authors:  Caroline C Jadlowiec; Timucin Taner
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

Review 5.  Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians.

Authors:  Carrie A Schinstock; Manish J Gandhi; Mark D Stegall
Journal:  Transplantation       Date:  2016-08       Impact factor: 4.939

6.  The impact of alloantibodies directed against the second donor on long-term outcomes of repeat liver transplantation.

Authors:  Qingyong Xu; Brad Shrum; Steve Leckie; Anton Skaro; Vivian C McAlister
Journal:  Hepatobiliary Surg Nutr       Date:  2019-06       Impact factor: 7.293

7.  Impact of Antibodies That React With Liver Tissue and Donor-Specific Anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis.

Authors:  Yoshihiro Hirata; Atsushi Yoshizawa; Hiroto Egawa; Daisuke Ueda; Shinya Okamoto; Hideaki Okajima; Kimiko Yurugi; Rie Hishida; Hideyo Hirai; Aya Miyagawa-Hayashino; Taira Maekawa; Hironori Haga; Sinji Uemoto
Journal:  Transplantation       Date:  2017-05       Impact factor: 4.939

8.  De Novo Donor Specific Antibody and Long-Term Outcome After Liver Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Zahra Beyzaei; Bita Geramizadeh; Zahra Bagheri; Sara Karimzadeh; Alireza Shojazadeh
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561

Review 9.  Updates on antibody-mediated rejection in intestinal transplantation.

Authors:  Guo-Sheng Wu
Journal:  World J Transplant       Date:  2016-09-24

10.  De Novo Donor-Specific HLA Antibody Formation in Two Patients With Crigler-Najjar Syndrome Type I Following Human Hepatocyte Transplantation With Partial Hepatectomy Preconditioning.

Authors:  C Jorns; G Nowak; A Nemeth; H Zemack; L-M Mörk; H Johansson; R Gramignoli; M Watanabe; A Karadagi; M Alheim; D Hauzenberger; R van Dijk; P J Bosma; F Ebbesen; A Szakos; B Fischler; S Strom; E Ellis; B-G Ericzon
Journal:  Am J Transplant       Date:  2015-11-02       Impact factor: 8.086
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.